EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies

Robert Blassberg

GEN Biotechnology · 2022

DOI: 10.1089/genbio.2021.0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GEN Biotechnology, 2022. Verfasst von Robert Blassberg. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The explosion of interest in CRISPR-Cas systems over recent years has delivered rapid advances in precision genome engineering technologies that hold enormous potential for application across the biotechnology sector. Within the cell therapy space, adoptive immunotherapies continue to lead the translation of increasingly sophisticated genetic engineering strategies toward clinical application. Although early focus was placed on engineering primary immune cells collected from patient blood, the democratization of these therapeutics will require the development of off-the-shelf allogeneic cell therapy products that can be manufactured at scale. Pluripotent stem cells (PSCs) represent an attractive substrate for such products, and many of the challenges that must be overcome to realize the application of PSCs in adoptive cell therapies are common with those holding back regenerative cell-replacement therapies. This article discusses how genome editing can overcome these challenges and highlights the potential of rapidly advancing second-generation technologies in the development of novel cell-based therapeutics.

Zitieren

APA

Blassberg, R. (2022). Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies. GEN Biotechnology. https://doi.org/10.1089/genbio.2021.0010

Vancouver

Blassberg R. Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies. GEN Biotechnology. 2022. doi:10.1089/genbio.2021.0010

BibTeX
@article{Blassberg2022,
  author = {Blassberg, Robert},
  title = {Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies},
  journal = {GEN Biotechnology},
  year = {2022},
  doi = {10.1089/genbio.2021.0010}
}
Kostenlos starten →